Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,227,690,080
-$3,414,876,805 QoQ
Shares Held
26,341,031
+2.4% QoQ
Ownership
2.80%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.209561994745.ToString("F0")%
Shared 0.ToString("F0")%
None 8.790438005254995.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FMR LLC holds $65,159,031,340 across 17 Drug Manufacturers - General names. LLY ranks #1 (37.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
26,341,031 | $24,227,690,080 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
71,906,290 | $10,021,579,632 | |
| 3 | JNJ |
Johnson & Johnson
|
24,771,828 | $6,055,225,633 | |
| 4 | AZN |
Astrazeneca PLC
|
29,601,724 | $5,838,052,004 | |
| 5 | MRK |
Merck & Co., Inc.
|
44,516,010 | $5,354,830,840 | |
| 6 | ABBV |
AbbVie Inc.
|
21,762,703 | $4,733,170,273 | |
| 7 | GSK |
GSK plc
|
67,661,646 | $3,734,246,242 | |
| 8 | BIIB |
Biogen Inc.
|
12,807,541 | $2,348,006,489 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,227,690,080 | 26,341,031 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,642,566,885 | 25,721,670 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $18,443,092,556 | 24,171,812 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,979,176,944 | 25,629,773 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,512,557,584 | 28,468,668 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $23,573,211,456 | 30,535,248 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $29,268,285,931 | 33,036,420 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $30,319,384,450 | 33,488,021 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,514,804,582 | 34,082,478 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $19,146,252,223 | 32,845,420 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,288,856,832 | 32,187,472 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,381,741,573 | 32,798,289 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,991,938,721 | 32,007,276 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $12,339,954,410 | 33,730,468 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $10,688,866,158 | 33,056,645 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,517,912,904 | 32,439,666 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,032,307,393 | 31,540,690 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,440,670,817 | 30,557,783 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,205,389,670 | 31,185,413 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $7,080,361,718 | 30,848,561 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,763,797,727 | 30,852,145 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,327,544,959 | 25,631,041 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $4,419,735,691 | 29,859,044 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,924,102,483 | 29,992,097 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $3,889,332,312 | 28,037,286 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||